Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
A Phase 2 Study of Once-Daily LY3502970 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities (ClinicalTrials.gov Identifier: NCT05051579)
For diabetics, this can result in hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar), both of which can be dangerous
Water counts
One of the most important outcomes is reduced risk of major cardiovascular events
Its important to stick to the recommended areas: the abdomen, thigh, or upper arm
Here are some key tips to consider when initiating treatment
US$ 25.95
US$ 20.20
US$ 22.61
US$ 28.82
US$ 26.81
US$ 28.72
US$ 23.64
